Literature DB >> 15935735

Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles.

Anahí Chavarría1, Agnes Fleury, Esperanza García, Carlos Márquez, Gladis Fragoso, Edda Sciutto.   

Abstract

Human neurocysticercosis is caused by the establishment of Taenia solium cysticerci in the central nervous system. Neurocysticercosis may be asymptomatic or manifested by non-specific mild to severe neurological symptoms. Host factors may be involved in this heterogeneous clinical picture. An immune-inflammatory profile that underlies neurocysticercosis presentation was determined in 45 cerebral spinal fluid (CSF), from clinical and radiologically characterized neurocysticercosis patients, measuring specific IgG subclasses and cytokines. Severity related with increased cellularity in the CSF which was characterized by increased levels of IgG subclasses, IL6/IL5/IL10, proteins, and eosinophils. Multiple neurocysticercosis showed higher levels of IL5/IL6 than single neurocysticercosis. Women presented increased IL6/IL5/IL10 levels pointing out immunological differences due to gender. Severe symptomatology was found when cysticerci were located intraventricular or in the subarachnoid space of the base, inducing an exacerbated response in the CSF. These results constitute an integrative insight to understand the immune-inflammatory response that underlies symptomatic neurocysticercosis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15935735     DOI: 10.1016/j.clim.2005.04.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  20 in total

1.  Is the presence of depression independent from signs of disease activity in patients with neurocysticercosis?

Authors:  Sergio Monteiro de Almeida; Solange Aparecida Gurjão
Journal:  J Community Health       Date:  2011-10

2.  Neurocysticercosis: local and systemic immune-inflammatory features related to severity.

Authors:  Brenda Sáenz; Agnes Fleury; Anahí Chavarría; Marisela Hernández; José C Crispin; María I Vargas-Rojas; Gladis Fragoso; Edda Sciutto
Journal:  Med Microbiol Immunol       Date:  2011-06-23       Impact factor: 3.402

3.  Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity.

Authors:  Graciela Cárdenas; Gladis Fragoso; Marcos Rosetti; Laura Uribe-Figueroa; Claudia Rangel-Escareño; Brenda Saenz; Marisela Hernández; Edda Sciutto; Agnes Fleury
Journal:  Med Microbiol Immunol       Date:  2014-06-24       Impact factor: 3.402

4.  Association of TRAF1/C5 Locus Polymorphisms with Epilepsy and Clinical Traits in Mexican Patients with Neurocysticercosis.

Authors:  Marcela Villegas; Edda Sciutto; Marcos Rosetti; Agnes Fleury; Gladis Fragoso
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

5.  Immune response in symptomatic and asymptomatic neurocysticercosis.

Authors:  Avantika Verma; Kashi N Prasad; Satyanarayana S Cheekatla; Kishan K Nyati; Vimal K Paliwal; Rakesh K Gupta
Journal:  Med Microbiol Immunol       Date:  2011-05-01       Impact factor: 3.402

6.  Neurocysticercosis, IgG immunoglobulins, and nitric oxide.

Authors:  Vasudevan Prabhakaran; Tharmalingam Jayaraman; Vedantam Rajshekhar; Anna Oommen
Journal:  Parasitol Res       Date:  2010-02-27       Impact factor: 2.289

Review 7.  Immunological and molecular diagnosis of cysticercosis.

Authors:  Silvia Rodriguez; Patricia Wilkins; Pierre Dorny
Journal:  Pathog Glob Health       Date:  2012-09       Impact factor: 2.894

8.  The Local Inflammatory Profile and Predictors of Treatment Success in Subarachnoid Neurocysticercosis.

Authors:  Sarah Harrison; Lauren Thumm; Theodore E Nash; Thomas B Nutman; Elise M O'Connell
Journal:  Clin Infect Dis       Date:  2021-05-04       Impact factor: 9.079

Review 9.  Granulocytes in helminth infection -- who is calling the shots?

Authors:  B L Makepeace; C Martin; J D Turner; S Specht
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

10.  Progesterone induces mucosal immunity in a rodent model of human taeniosis by Taenia solium.

Authors:  Galileo Escobedo; Ignacio Camacho-Arroyo; Paul Nava-Luna; Alfonso Olivos; Armando Pérez-Torres; Sonia Leon-Cabrera; J C Carrero; Jorge Morales-Montor
Journal:  Int J Biol Sci       Date:  2011-11-10       Impact factor: 6.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.